Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Debt Ratio: 2020-2023

Historic Debt Ratio for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to 0.41.

  • Candel Therapeutics' Debt Ratio rose 72.48% to 0.41 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.41, marking a year-over-year increase of 72.48%. This contributed to the annual value of 0.26 for FY2022, which is 4042.14% up from last year.
  • As of Q3 2023, Candel Therapeutics' Debt Ratio stood at 0.41, which was up 17.76% from 0.35 recorded in Q2 2023.
  • Candel Therapeutics' Debt Ratio's 5-year high stood at 0.41 during Q3 2023, with a 5-year trough of 0.01 in Q4 2021.
  • Its 3-year average for Debt Ratio is 0.25, with a median of 0.25 in 2022.
  • In the last 5 years, Candel Therapeutics' Debt Ratio plummeted by 48.09% in 2021 and then skyrocketed by 4,042.14% in 2022.
  • Over the past 4 years, Candel Therapeutics' Debt Ratio (Quarterly) stood at 0.01 in 2020, then crashed by 48.09% to 0.01 in 2021, then surged by 4,042.14% to 0.26 in 2022, then surged by 72.48% to 0.41 in 2023.
  • Its last three reported values are 0.41 in Q3 2023, 0.35 for Q2 2023, and 0.30 during Q1 2023.